Goodman, Matthew O. https://orcid.org/0000-0002-3982-7940
Faquih, Tariq https://orcid.org/0000-0001-8026-2251
Paz, Valentina
Nagarajan, Pavithra https://orcid.org/0000-0002-0036-9970
Lane, Jacqueline M.
Spitzer, Brian
Maher, Matthew
Chung, Joon
Cade, Brian E. https://orcid.org/0000-0003-1424-0673
Purcell, Shaun M. https://orcid.org/0000-0002-7402-5812
Zhu, Xiaofeng https://orcid.org/0000-0003-0037-411X
Noordam, Raymond https://orcid.org/0000-0001-7801-809X
Phillips, Andrew J. K.
Kyle, Simon D.
Spiegelhalder, Kai
Weedon, Michael N. https://orcid.org/0000-0002-6174-6135
Lawlor, Deborah A. https://orcid.org/0000-0002-6793-2262
Rotter, Jerome I. https://orcid.org/0000-0001-7191-1723
Taylor, Kent D.
Isasi, Carmen R. https://orcid.org/0000-0003-2700-9593
Sofer, Tamar https://orcid.org/0000-0001-8520-8860
Dashti, Hassan S. https://orcid.org/0000-0002-1650-679X
Rutter, Martin K.
Redline, Susan https://orcid.org/0000-0002-6585-1610
Saxena, Richa
Wang, Heming https://orcid.org/0000-0002-1486-7495
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL153814, R01HL146751, R35HL135818)
Article History
Received: 11 March 2024
Accepted: 10 January 2025
First Online: 24 January 2025
Competing interests
: The authors declare the following competing interests: A.J.K.P. has received research funding from Versalux and Delos, and he is co-founder and co-director of Circadian Health Innovations PTY LTD. S.R. received consulting fees from Jazz Pharma, Eli Lilly, and ApniMed Inc. Martin Rutter has received consulting fees from Eli Lilly. All other authors declare no competing interests.